Cointime

Valeo Pharma

company

About

Valeo Pharma is committed to provide healthcare professionals and patients with therapeutic solutions.

  • 101 - 250

Highlights

Total Funding Amount
$40M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$40M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2003
Number Of Employee
101 - 250
Operating Status
Active

Valeo Pharma is devoted to providing healthcare professionals and patients with the highest quality specialty products and healthcare solutions. Valeo Pharma concentrates on the commercialization of specialized innovative products addressing the needs of patients suffering from complicated or rare diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$40M
Valeo Pharma has raised a total of $40M in funding over 2 rounds. Their latest funding was raised on Aug 2, 2022 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 2, 2022 Post-IPO Debt $40M 1 Sagard Healthcare Royalty Partners — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Valeo Pharma is funded by 1 investors. Sagard Healthcare Royalty Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Sagard Healthcare Royalty Partners Yes Post-IPO Debt
Cointime
เนื้อหา
บริษัท